Bill Gates’s Anheuser-Busch InBev (BUD) position
Reported position history, portfolio importance and verified filing changes from public SEC disclosures.
At a glance
The full verified relationship, including prior ownership episodes and exits where supported.
Gates Foundation Trust first reported Anheuser-Busch InBev in Q2 2023. Gates Foundation Trust currently reports 1.70M shares. The latest verified filing showed: No change.
Position over time
See the same verified relationship through reported shares, portfolio weight or reported value.
Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.
What changed
Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.
Filing context
Quarter-end price $82.40 · Estimated holding basis $56.72
Filing context
Quarter-end price $69.37 · Estimated holding basis $56.72
Filing context
Quarter-end price $64.04 · Estimated holding basis $56.72
Filing context
Quarter-end price $59.61 · Estimated holding basis $56.72
Filing context
Quarter-end price $68.72 · Estimated holding basis $56.72
Filing context
Quarter-end price $61.56 · Estimated holding basis $56.72
Filing context
Quarter-end price $50.07 · Estimated holding basis $56.72
Filing context
Quarter-end price $66.29 · Estimated holding basis $56.72
Filing context
Quarter-end price $58.15 · Estimated holding basis $56.72
Filing context
Quarter-end price $60.78 · Estimated holding basis $56.72
Filing context
Quarter-end price $64.62 · Estimated holding basis $56.72
Filing context
Quarter-end price $55.30 · Estimated holding basis $56.72
Filing context
Quarter-end price $56.72 · Estimated holding basis $56.72
11 unchanged quarters are collapsed by default.
How important is Anheuser-Busch InBev in Gates Foundation Trust’s reported portfolio?
Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.
Connected research on Anheuser-Busch InBev
Only published MIL research mapped to the exact stock identity is shown here.
SEC filing evidence
Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.
Market context only; not an investor transaction price.
Derived from validated reported value and shares where supported.
Calculated from supported filing history.
View Anheuser-Busch InBev stock page →
This tracker follows the Gates Foundation Trust’s Form 13F disclosures. It is not Bill Gates’s personal brokerage account, and 13F filings do not reveal exact trade dates or execution prices.